Reviva pharmaceuticals to participate in the upcoming january virtual investor conferences

Cupertino, calif., dec. 20, 2021 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), cardiovascular, metabolic, and inflammatory diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will participate in the following conferences in january and invites investors to participate in virtual one-on-one meetings. please see additional details below:
RVPH Ratings Summary
RVPH Quant Ranking